SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks
SYNSORB (T.SYB)(SYBBF) CURE FOR CANCER?
An SI Board Since February 1999
Posts SubjectMarks Bans Symbol
164 11 0 SYB
Emcee:  Tupulak Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
139Oncolytics Biotech Inc. Reports Financial Results for 2000 Business Editors Jim Oravetz-3/14/2001
138Oncolytics Biotech Interview on World Business Review with Alexander Haig. (Synsblue_chip-3/10/2001
137Jim, Given that the value of the ONC held by SYB is more than the entire value DaveAu-3/1/2001
136Semi-OT:Oncolytics Biotech's Reolysin Drug Reduces Tumors In Mice Dow Jones Jim Oravetz-3/1/2001
135Wow ... how far can you average down. Aren't we past book value by now ?W. Randy Gast-12/20/2000
134I'm in today at 2.00. I think the correction is way overdone here. The E colDaveAu-12/14/2000
133Synsorb Biotech Won't Pursue Further Devt Of Synsorb Pk Dow Jones Newswires Jim Oravetz-12/14/2000
132SYNSORB Biotech Inc. today announced that their affiliate company, Oncolytics BiJim Oravetz-11/21/2000
131SYNSORB Biotech Inc.(TSE:SYB.)(Nasdaq:SYBB) today reported its results for the tJim Oravetz-11/20/2000
130Semi-OT CALGARY, Alberta-(BW)-Nov. 10-Oncolytics Biotech Inc. (TSE:ONC.) reporteJim Oravetz-11/10/2000
129Tuesday September 26, 7:16 am Eastern Time Press Release SYNSORB Biotech Inc. tnsaf-9/26/2000
128It is estimated that 3.5 million people suffer C. difficile infections annually Jim Oravetz-9/6/2000
127News Release Oncolytics Biotech Inc. Receives U.S. Patent Approval blue_chip-9/1/2000
126semi-OT:CALGARY, Alberta--(BUSINESS WIRE)--Sept. 1, 2000--Oncolytics Biotech IncJim Oravetz-9/1/2000
125semi-OT:Aug. 28, 2000--Oncolytics Biotech Inc. ("Oncolytics") (TSE:ONCJim Oravetz-8/28/2000
124E. Coli: The Good, the Bad and the Fatal ...In three to 20 percent of cases, moJim Oravetz-8/11/2000
123CALGARY (Dow Jones)--Synsorb Biotech Inc. (SYBB, news, msgs) has received authorJim Oravetz-8/3/2000
122SYNSORB Biotech Inc., will host a dial-in conference call with David J. Cox, Ph.Jim Oravetz-7/18/2000
121E. coli's Death Grip on Intestinal Cells July 6, 2000 CHEVY CHASE, MD---A tJim Oravetz-7/17/2000
120Synsorb Biotech Sinks After Synsorb Pk Results By MARY WEIL TORONTO -- Synsorb Jim Oravetz-7/13/2000
119Jim, this is great news. 59% risk reduction if treated within 2 days of symptomsrichard wilson-7/13/2000
118SYNSORB Biotech Inc. Announces Outcome Of Interim Analysis of SYNSORB Pk Phase IJim Oravetz-7/13/2000
117Taking Antibiotics? Eat Yogurt! November 29, 1999 A study conducted at the UnivJim Oravetz-7/6/2000
116This is from an January 11, 2000 PR CDAD is a disease which is a common complicJim Oravetz-7/6/2000
115Here was the Nov. '99 Press report - before the more rigid standards were usJim Oravetz-7/6/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News